Left Atrial Appendage Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: Prevalence and Risk Factors
LAAT is common in patients with HCM and AF, even among those receiving OAC. Reduced LAA flow velocity may increase thrombus risk. TEE should be considered before rhythm-control strategies, even in patients with HCM receiving anticoagulation, to minimize thromboembolic complications.
Authors
- Ruben Schleberger (ORCID: https://orcid.org/0000-0003-3798-6427)
- Fabian Moser (ORCID: https://orcid.org/0000-0001-7310-6111)
- Jannis Dickow (ORCID: https://orcid.org/0000-0002-0374-4983)
- Laura Rottner (ORCID: https://orcid.org/0000-0002-1389-8564)
- Andreas Rillig
- B. Lippmann
- Leon Dinshaw (ORCID: https://orcid.org/0000-0002-1473-5716)
- M PATTEN
- Paula Münkler (ORCID: https://orcid.org/0000-0002-4104-0012)
- Marc D. Lemoine (ORCID: https://orcid.org/0000-0002-3799-7962)
- Bruno Reißmann
- Paulus Kirchhof
- Feifan Ouyang
- Henrik Schneider
- Andreas Metzner
Institutions
- Universität Hamburg (DE)
- Wismar University of Applied Sciences (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- German Centre for Cardiovascular Research (DE)
- Albertinen Diakoniewerk (DE)
- University of Birmingham (GB)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1161/jaha.125.042010
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00